InvestorsHub Logo
Followers 35
Posts 1393
Boards Moderated 0
Alias Born 09/09/2009

Re: None

Wednesday, 09/03/2014 2:09:49 PM

Wednesday, September 03, 2014 2:09:49 PM

Post# of 144823
I guess there is still some misunderstanding about what is going on in Nuvilex...the Orphan Drug Designation for EU that we just applied for... is for the Late Phase 2b trial that is being conducted which when completed Nuvilex will apply for approval in the EU...Australia...and the U.S. not the preclinical that Dr.Von Hoff and TD2 are conducting right now...

I hope this clears things up ...
bull
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PMCB News